Moderna gains on report it held talks with at least one large drugmaker
Update 12:30pm:Adds Moderna cancelling from a conference.
	- Moderna (MRNA)rose 12%after a report that it has held talks with at least one large drugmaker on a deal of significant scope, according to a STAT News report.
- A takeoveror a large partnership was on the table, according to theSTAT News itemon Thursday, which cited one person familiar with the discussions. The precise nature of the potential agreement was unclear.
- Moderna didnt immediately respond to Seeking Alphas request for comment.
- Separately on Thursday, Moderna (MRNA) cancelled from a UBS Global Healthcare conference scheduled for Nov. 9 - Nov. 12 in Palm Beach Gardens, Florida. Moderna cancelled from the conference due to scheduling conflicts, according to an email viewed by Seeking Alpha.